PEG-IFN α-2a

pegylated interferon alfa-2a

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PEG-IFN α-2a, covering 2024-04-04 to 2024-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety and Efficacy of ASC42 Combined With ETV and PEG-IFN α-2a in Subjects With HBV [Phase 2]